title: Kinin B2 receptor localization and expression in the hypothalamo-pituitary-adrenal axis of spontaneously hypertensive rats.
abstract: OBJECTIVE
  An enhanced hypothalamo-pituitary-adrenocortical (HPA) activity has been demonstrated during onset of high blood pressure in spontaneously hypertensive rats (SHR). Furthermore, compared to normotensive Wistar-Kyoto (WKY) rats, SHR show hypersensitivity to bradykinin (BK)-induced pressor responses which may be caused by an upregulation of B(2) receptor expression in the brain.
  
  
  METHODS
  We performed an immunohistochemical localization and measured gene expression of B(2) receptors in the hypothalamus, pituitary and adrenal glands of SHR at three ages corresponding to the development of hypertension, i.e. prehypertensive phase, onset of hypertension and established hypertension. Using reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot technique, B(2) receptor mRNA and protein levels, respectively, were measured.
  
  
  RESULTS
  A specific immunostaining for B(2) receptors was observed in the hypothalamic nuclei paraventricularis (PVN) and supraopticus (SON). In the pituitary and adrenal glands, a strong immunostaining was observed in neurohypophysis (NH) and adrenal medulla, respectively. At all ages tested, B(2) receptor mRNA and protein levels were higher in the hypothalamus and adrenal glands of SHR compared to age-matched WKY rats. Among SHR, the mRNA level was increased in neurohypophysis with age, and no difference was found in the adenohypophysis (AH) between SHR and WKY rats.
  
  
  CONCLUSIONS
  The data demonstrate a specific localization and an upregulation of B(2) receptor expression in the hypothalamus and adrenal glands of SHR, providing an anatomical and molecular basis for a possible contributory role to bradykinin-induced hypersensitivity of cardiovascular responses. The increased B(2) receptor expression in the hypothalamus and adrenal glands may also play a role in the abnormalities of the HPA axis in SHR during the development of hypertension.
authors.affiliation: Institute of Experimental and Clinical Pharmacology and Toxicology, University Clinic of Lübeck, Ratzeburger Allee 160, D-23538 Lübeck, Germany. qadri@medinf.mu-luebeck.de
authors.forename: Fatimunnisa
authors.initials: F
authors.lastname: Qadri
authors.forename: Eike C
authors.initials: EC
authors.lastname: Schwartz
authors.forename: Walter
authors.initials: W
authors.lastname: Häuser
authors.forename: Olaf
authors.initials: O
authors.lastname: Jöhren
authors.forename: Werner
authors.initials: W
authors.lastname: Müller-Esterl
authors.forename: Peter
authors.initials: P
authors.lastname: Dominiak
mesh_terms: D000375:Aging / Q000378:metabolism; D000818:Animals; D015153:Blotting, Western; D006973:Hypertension / Q000235:genetics / Q000378:metabolism*; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism*; D007150:Immunohistochemistry; D008297:Male; D010913:Pituitary-Adrenal System / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis / Q000302:isolation & purification; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D043782:Receptor, Bradykinin B2 / Q000096:biosynthesis* / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015854:Up-Regulation
chemical_list: D012333:RNA, Messenger; D043782:Receptor, Bradykinin B2